Corrigendum: rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis

• Weiran Shen,
• Shengjiang Liu,
• Li Ou,
• Li Ou

Affiliations

Weiran Shen

Obio Technologies, Shanghai, China

Shengjiang Liu

Avirmax Inc, Hayward, CA, United States

Li Ou

Genemagic Biosciences, Wallingford, PA, United States

Li Ou

Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States